skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

About Ayisha


1+ years of experience

Ayisha Sharma Headshot
Ayisha Sharma report on a drug development across range of therapeutic areas including oncology, neurology and rare diseases. She particularly interested in writing on psychiatry and novel drug development in this space, such as psychedelics, and the emergence of microbiome modulators.

She joined Informa in 2021.


Her current areas of expertise are rare diseases, psychiatry and microbiome modulation.


She previously worked as a reporter at BioPharm Insight, where she covered the beats of hematology, oncology and rare diseases.


Her biggest achievement was writing an article about what big pharma’s must do to help tackle antimicrobial resistance and the future of consolidation and partnerships in this space, based on an interview with the Access to Medicines foundation. 

Analyst Articles